0001665160-18-000859.txt : 20180828 0001665160-18-000859.hdr.sgml : 20180828 20180828132851 ACCESSION NUMBER: 0001665160-18-000859 CONFORMED SUBMISSION TYPE: C/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180828 DATE AS OF CHANGE: 20180828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioclonetics Immunotherapeutics, Inc. CENTRAL INDEX KEY: 0001701251 IRS NUMBER: 680679610 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C/A SEC ACT: 1933 Act SEC FILE NUMBER: 020-23900 FILM NUMBER: 181041114 BUSINESS ADDRESS: STREET 1: 1756 BISON MEADOW LANE CITY: HEATH STATE: TX ZIP: 75032 BUSINESS PHONE: 2142932436 MAIL ADDRESS: STREET 1: 1756 BISON MEADOW LANE CITY: HEATH STATE: TX ZIP: 75032 C/A 1 primary_doc.xml C/A 0001701251 XXXXXXXX 020-23900 LIVE false false false true Issuer is extending their campaign. Bioclonetics Immunotherapeutics, Inc. Corporation TX 12-24-2009 1756 BISON MEADOW LANE HEATH TX 75032 www.bioclonetics.com StartEngine Capital, LLC 0001665160 007-00007 6 percent N/A Other Convertible Note 10000 1.00000 N/A 10000.00 Y Other At issuer's discretion 683234.00 11-02-2018 4.00 183622.00 1195.00 183622.00 1195.00 0.00 0.00 45285.00 32154.00 386766.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -217470.00 -95511.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Bioclonetics Immunotherapeutics, Inc. Charles S. Cotropia CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer Charles S. Cotropia CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer 08-28-2018